Seriously Ill Patients' Willingness to Trade Survival Time to Avoid High Treatment Intensity at the End of Life

Emily B Rubin; Anna Buehler; Scott D Halpern

doi:10.1001/jamainternmed.2020.0681

Seriously Ill Patients' Willingness to Trade Survival Time to Avoid High Treatment Intensity at the End of Life

JAMA Intern Med. 2020 Jun 1;180(6):907-909. doi: 10.1001/jamainternmed.2020.0681.

Authors

Emily B Rubin¹, Anna Buehler², Scott D Halpern³

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston.
² University of California, San Diego School of Medicine, San Diego.
³ The Palliative and Advanced Illness Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.

Abstract

This cohort study quantifies trade-offs between survival time and avoidance of intensive care near the end of life among seriously ill hospitalized patients.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Aged
Cost of Illness*
Critical Illness / economics
Critical Illness / mortality*
Critical Illness / therapy
Decision Making*
Disease Management*
Female
Follow-Up Studies
Humans
Male
Middle Aged
Prospective Studies
Survival Rate / trends
Terminal Care / economics*
United States / epidemiology